Losmapimod has the potential to be the first drug to treat FSHD The much-anticipated Phase 3 clinical trial of losmapimod has formally begun with the dosing of the first volunteer, […]
First patient enrolls in Fulcrum’s Phase 3 clinical trial
ReDUX4 trial result exceeds expectations
[…] Engagement “Positive benefit/risk supports losmapimod’s potential to be a transformative therapy for the treatment of FSHD”-Fulcrum Therapeutics Fulcrum Therapeutics announced today that losmapimod, its experimental therapy for facioscapulohumeral muscular dystrophy, […]
Fulcrum’s interim findings from ReDUX4 trial are “encouraging”
[…] testing the effect of a drug called losmapimod in individuals with facioscapulohumeral muscular dystrophy ( FSHD). The drug, which is taken as a pill twice a day, is intended to […]
The very model of a modern epigenetic disease
[…] but they are severely hypomethylated. (Figure courtesy of Peter Jones, PhD.) Yes, we’re talking about FSHD On those rare occasions (such as the FSHD Connect meeting) when large numbers of […]
Tampa Chapter
Welcome to the Tampa Chapter! Thank you for visiting the Tampa Chapter of the FSHD Society which officially launched in May 2019. We are here to build a local community […]